SLC5A2 and Cognitive impairment: Although this study indicates a favorable effect of henagliflozin on reducing cognitive impairment, it also underscores the need for further investigations to determine the potential clinical benefits of different SGLT2 inhibitors in improving cognitive outcomes [14].